Intranasal Insulin for COVID-19-related Smell Loss

Clinical trial NCT05461365 · COMPLETED

Trial details

NCT number: NCT05461365
Sponsor: Universidad Panamericana
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Anosmia Smell Loss Paraosmia Hyposmia COVID-19

Start date: 2021-01-04
Primary completion: 2021-11-25
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.